User profiles for Yoon Hong Choi
Yoon Hong ChoiPublic Health England Verified email at phe.gov.uk Cited by 2699 |
Economic evaluation of human papillomavirus vaccination in the United Kingdom
Objective To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls
against human papillomavirus infection in the United Kingdom. Design Economic evaluation. …
against human papillomavirus infection in the United Kingdom. Design Economic evaluation. …
Association of sinoatrial node radiation dose with atrial fibrillation and mortality in patients with lung cancer
… Author Contributions: KH Kim and HI Yoon had full access to all of the data in the study and
take responsibility for the integrity of the … Drs Kang and Yoon jointly supervised this work. …
take responsibility for the integrity of the … Drs Kang and Yoon jointly supervised this work. …
Comparing bivalent and quadrivalent human papillomavirus vaccines: economic evaluation based on transmission model
Objectives To compare the effect and cost effectiveness of bivalent and quadrivalent human
papillomavirus (HPV) vaccination, taking into account differences in licensure indications, …
papillomavirus (HPV) vaccination, taking into account differences in licensure indications, …
The impact of the national HPV vaccination program in England using the bivalent HPV vaccine: surveillance of type-specific HPV in young females, 2010–2016
…, SL Thomas, C Edmundson, YH Choi… - The Journal of …, 2018 - academic.oup.com
Background The national human papillomavirus (HPV) immunization program was introduced
in England in September 2008 using the bivalent vaccine. Methods We collected residual …
in England in September 2008 using the bivalent vaccine. Methods We collected residual …
Transarterial chemoembolization vs. radiofrequency ablation for the treatment of single hepatocellular carcinoma 2 cm or smaller
…, PN Kim, HK Choi, GY Ko, HK Yoon… - Official journal of the …, 2014 - journals.lww.com
OBJECTIVES: To compare the effectiveness of transarterial chemoembolization (TACE) and
radiofrequency ablation (RFA) for treating small (≤ 2 cm) hepatocellular carcinomas (HCCs)…
radiofrequency ablation (RFA) for treating small (≤ 2 cm) hepatocellular carcinomas (HCCs)…
Transmission dynamic modelling of the impact of human papillomavirus vaccination in the United Kingdom
Many countries are considering vaccination against human papillomavirus (HPV). However,
the long-term impact of vaccination is difficult to predict due to uncertainty about the …
the long-term impact of vaccination is difficult to predict due to uncertainty about the …
[HTML][HTML] Dynamic models of pneumococcal carriage and the impact of the Heptavalent Pneumococcal Conjugate Vaccine on invasive pneumococcal disease
Background The 7-valent pneumococcal conjugate vaccine has been introduced in national
immunisation programmes of most industrialised countries and recently in two African GAVI …
immunisation programmes of most industrialised countries and recently in two African GAVI …
Comparison of two dose and three dose human papillomavirus vaccine schedules: cost effectiveness analysis based on transmission model
Objective To investigate the incremental cost effectiveness of two dose human papillomavirus
vaccination and of additionally giving a third dose. Design Cost effectiveness study based …
vaccination and of additionally giving a third dose. Design Cost effectiveness study based …
[HTML][HTML] Investigating the pertussis resurgence in England and Wales, and options for future control
YH Choi, H Campbell, G Amirthalingam, AJ Van Hoek… - BMC medicine, 2016 - Springer
Background In 2012 England and Wales experienced a resurgence of pertussis and an
increase in infant deaths. This occurred 8 years after acellular pertussis (aP) vaccine replaced …
increase in infant deaths. This occurred 8 years after acellular pertussis (aP) vaccine replaced …
[HTML][HTML] Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+ 1 to 1+ 1 in England and Wales: a modelling study
Background In October 2017, the United Kingdom Joint Committee on Vaccination and
Immunisation (JCVI) recommended removal of one primary dose of the 13-valent pneumococcal …
Immunisation (JCVI) recommended removal of one primary dose of the 13-valent pneumococcal …